FDA Approved: BERKLEY AND JENSEN OMEPRAZOLE — Supplemental Application (BJWC)

View source ↗

Summary

The FDA approved a supplemental application for Berkley and Jensen Omeprazole (omeprazole) submitted by BJWC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Helicobacter Pylori Infection
• Peptic Ulcer Disease

Drugs mentioned

• BERKLEY AND JENSEN OMEPRAZOLE (omeprazole)

Snippet

SUPPL AP for BERKLEY AND JENSEN OMEPRAZOLE (OMEPRAZOLE)